Anti‐inflammatory evaluation of cryogenine
Identifieur interne : 003D10 ( Main/Exploration ); précédent : 003D09; suivant : 003D11Anti‐inflammatory evaluation of cryogenine
Auteurs : Harvey R. Kaplan [États-Unis] ; Richard E. Wolke [États-Unis] ; Marvin H. Malone [États-Unis]Source :
- Journal of Pharmaceutical Sciences [ 0022-3549 ] ; 1967-11.
English descriptors
- Teeft :
- Abdominal skin, Adjuvant, Analgesia, Analgesic, Analgesic activity, Antagonism studies, Antiphlogistic evaluation, Antipyretic, Antipyretic evaluation, Aqueous solution, Aspirin, Body weight, Bone proliferation, Bradykinin, Caliper technique, Carrageenin, Carrageenin injection, Cent analgesia, Chloroquine, Cinnamic acid, Clot lysis, Consultants bureau, Contralateral foot, Control animal, Control animals, Creatinine sulfate, Cryogenine, Cryogenine base, Cryogeninetreated rats, Daily administration, Detectable lysis, Drug administration, Edema, Electric timer, Experimental procedures, Femorotibial articulations, Foot thickness, Histamine, Histamine diphosphate, Histopathological studies, Indomethacin, Inflammatory response, Inflammatory responses, Injection, Joint cavity, Keinhold publishing corp, Lesion, Local suppliers, Medial foot thickness, Metatarsal areas, Mononuclear cells, Multiple range test, Mycobacterium adjuvant, Narcotic analgesics, Oral dosage, Pain responses, Pharmaceutical sciences, Phenylbutazone, Plantar aponeurosis, Plantar injection, Preformed clots, Present address, Rat, Reaction time, Reaction times, Rectal temperatures, Reference agents, Sediment formation, Serotonin, Significant analgesia, Significant difference, Significant protection, Silver nitrate, Sparteine, Standard errors, Synovial membrane, Synthetic bradykinin, Tail flick, Test drugs, Test group, Thickness right feet, Transverse sections, Treatment effects, Treatment groups, Untreated controls.
Abstract
Cryogenine was effective in limiting the development of artificially induced inflammatory responses in acute and chronic experiments in rats. Cryogenine altered the acute edematous reaction to plantar injection of carrageenin and inhibited development of increased foot thickness induced by plantar injection of nonviable mycobacterial adjuvant in chronic studies. Histopathologic examinations did not suggest actions that would interfere with the anti‐inflammatory evaluations. Cryogenine demonstrated a low order of analgesic (rat tail flick) and antipyretic (peptone fever) activity, and was capable of partially reversing edema and pain produced by silver nitrate injections in the ankle joints of rats. Cryogenine blocked serotonin, bradykinin, and histamine responses in guinea pig ileum; and pretreatment limited serotonin‐induced pedal edema in rats and blocked histamine‐induced intradermal wheals in the rabbit. Cryogenine was ineffective as a fibrinolytic agent. Prototype nonsteroidal anti‐inflammatory compounds as well as agents with structural similarities to cryogenine were also investigated. Cryogenine may, like aspirin, manifest its anti‐inflammatory activity through a combination of selective central and nonspecific peripheral mechanisms.
Url:
DOI: 10.1002/jps.2600561103
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A47
- to stream Istex, to step Curation: 000A47
- to stream Istex, to step Checkpoint: 002A34
- to stream Main, to step Merge: 003D96
- to stream Main, to step Curation: 003D10
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anti‐inflammatory evaluation of cryogenine</title>
<author><name sortKey="Kaplan, Harvey R" sort="Kaplan, Harvey R" uniqKey="Kaplan H" first="Harvey R." last="Kaplan">Harvey R. Kaplan</name>
</author>
<author><name sortKey="Wolke, Richard E" sort="Wolke, Richard E" uniqKey="Wolke R" first="Richard E." last="Wolke">Richard E. Wolke</name>
</author>
<author><name sortKey="Malone, Marvin H" sort="Malone, Marvin H" uniqKey="Malone M" first="Marvin H." last="Malone">Marvin H. Malone</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E6DC3B41F2DCDF311C07136473051D3434C2AE8D</idno>
<date when="1967" year="1967">1967</date>
<idno type="doi">10.1002/jps.2600561103</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-86DQJ870-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A47</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A47</idno>
<idno type="wicri:Area/Istex/Curation">000A47</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A34</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002A34</idno>
<idno type="wicri:doubleKey">0022-3549:1967:Kaplan H:anti:inflammatory:evaluation</idno>
<idno type="wicri:Area/Main/Merge">003D96</idno>
<idno type="wicri:Area/Main/Curation">003D10</idno>
<idno type="wicri:Area/Main/Exploration">003D10</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Anti‐inflammatory evaluation of cryogenine</title>
<author><name sortKey="Kaplan, Harvey R" sort="Kaplan, Harvey R" uniqKey="Kaplan H" first="Harvey R." last="Kaplan">Harvey R. Kaplan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Division of Pharmacology, Pharmacy Research Institute, University of Connecticut, Storrs</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Current Address: Warner‐Lambert Research Institute, Morris Plains</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Wolke, Richard E" sort="Wolke, Richard E" uniqKey="Wolke R" first="Richard E." last="Wolke">Richard E. Wolke</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Division of Pharmacology, Pharmacy Research Institute, University of Connecticut, Storrs</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Current Address: Department of Animal Diseases, University of Connecticut, Storrs</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Malone, Marvin H" sort="Malone, Marvin H" uniqKey="Malone M" first="Marvin H." last="Malone">Marvin H. Malone</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Division of Pharmacology, Pharmacy Research Institute, University of Connecticut, Storrs</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Pharmaceutical Sciences</title>
<title level="j" type="alt">JOURNAL OF PHARMACEUTICAL SCIENCES</title>
<idno type="ISSN">0022-3549</idno>
<idno type="eISSN">1520-6017</idno>
<imprint><biblScope unit="vol">56</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1385">1385</biblScope>
<biblScope unit="page" to="1392">1392</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Washington</pubPlace>
<date type="published" when="1967-11">1967-11</date>
</imprint>
<idno type="ISSN">0022-3549</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-3549</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abdominal skin</term>
<term>Adjuvant</term>
<term>Analgesia</term>
<term>Analgesic</term>
<term>Analgesic activity</term>
<term>Antagonism studies</term>
<term>Antiphlogistic evaluation</term>
<term>Antipyretic</term>
<term>Antipyretic evaluation</term>
<term>Aqueous solution</term>
<term>Aspirin</term>
<term>Body weight</term>
<term>Bone proliferation</term>
<term>Bradykinin</term>
<term>Caliper technique</term>
<term>Carrageenin</term>
<term>Carrageenin injection</term>
<term>Cent analgesia</term>
<term>Chloroquine</term>
<term>Cinnamic acid</term>
<term>Clot lysis</term>
<term>Consultants bureau</term>
<term>Contralateral foot</term>
<term>Control animal</term>
<term>Control animals</term>
<term>Creatinine sulfate</term>
<term>Cryogenine</term>
<term>Cryogenine base</term>
<term>Cryogeninetreated rats</term>
<term>Daily administration</term>
<term>Detectable lysis</term>
<term>Drug administration</term>
<term>Edema</term>
<term>Electric timer</term>
<term>Experimental procedures</term>
<term>Femorotibial articulations</term>
<term>Foot thickness</term>
<term>Histamine</term>
<term>Histamine diphosphate</term>
<term>Histopathological studies</term>
<term>Indomethacin</term>
<term>Inflammatory response</term>
<term>Inflammatory responses</term>
<term>Injection</term>
<term>Joint cavity</term>
<term>Keinhold publishing corp</term>
<term>Lesion</term>
<term>Local suppliers</term>
<term>Medial foot thickness</term>
<term>Metatarsal areas</term>
<term>Mononuclear cells</term>
<term>Multiple range test</term>
<term>Mycobacterium adjuvant</term>
<term>Narcotic analgesics</term>
<term>Oral dosage</term>
<term>Pain responses</term>
<term>Pharmaceutical sciences</term>
<term>Phenylbutazone</term>
<term>Plantar aponeurosis</term>
<term>Plantar injection</term>
<term>Preformed clots</term>
<term>Present address</term>
<term>Rat</term>
<term>Reaction time</term>
<term>Reaction times</term>
<term>Rectal temperatures</term>
<term>Reference agents</term>
<term>Sediment formation</term>
<term>Serotonin</term>
<term>Significant analgesia</term>
<term>Significant difference</term>
<term>Significant protection</term>
<term>Silver nitrate</term>
<term>Sparteine</term>
<term>Standard errors</term>
<term>Synovial membrane</term>
<term>Synthetic bradykinin</term>
<term>Tail flick</term>
<term>Test drugs</term>
<term>Test group</term>
<term>Thickness right feet</term>
<term>Transverse sections</term>
<term>Treatment effects</term>
<term>Treatment groups</term>
<term>Untreated controls</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Cryogenine was effective in limiting the development of artificially induced inflammatory responses in acute and chronic experiments in rats. Cryogenine altered the acute edematous reaction to plantar injection of carrageenin and inhibited development of increased foot thickness induced by plantar injection of nonviable mycobacterial adjuvant in chronic studies. Histopathologic examinations did not suggest actions that would interfere with the anti‐inflammatory evaluations. Cryogenine demonstrated a low order of analgesic (rat tail flick) and antipyretic (peptone fever) activity, and was capable of partially reversing edema and pain produced by silver nitrate injections in the ankle joints of rats. Cryogenine blocked serotonin, bradykinin, and histamine responses in guinea pig ileum; and pretreatment limited serotonin‐induced pedal edema in rats and blocked histamine‐induced intradermal wheals in the rabbit. Cryogenine was ineffective as a fibrinolytic agent. Prototype nonsteroidal anti‐inflammatory compounds as well as agents with structural similarities to cryogenine were also investigated. Cryogenine may, like aspirin, manifest its anti‐inflammatory activity through a combination of selective central and nonspecific peripheral mechanisms.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Connecticut</li>
<li>New Jersey</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Kaplan, Harvey R" sort="Kaplan, Harvey R" uniqKey="Kaplan H" first="Harvey R." last="Kaplan">Harvey R. Kaplan</name>
</region>
<name sortKey="Kaplan, Harvey R" sort="Kaplan, Harvey R" uniqKey="Kaplan H" first="Harvey R." last="Kaplan">Harvey R. Kaplan</name>
<name sortKey="Malone, Marvin H" sort="Malone, Marvin H" uniqKey="Malone M" first="Marvin H." last="Malone">Marvin H. Malone</name>
<name sortKey="Wolke, Richard E" sort="Wolke, Richard E" uniqKey="Wolke R" first="Richard E." last="Wolke">Richard E. Wolke</name>
<name sortKey="Wolke, Richard E" sort="Wolke, Richard E" uniqKey="Wolke R" first="Richard E." last="Wolke">Richard E. Wolke</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E6DC3B41F2DCDF311C07136473051D3434C2AE8D |texte= Anti‐inflammatory evaluation of cryogenine }}
This area was generated with Dilib version V0.6.33. |